"Within two days at the hospital, by day three, they called my family to come and say goodbye," she tells PEOPLE ...

The near-term outlook for ClearPoint's biopharma business is also now clouded by FDA uncertainty around uniQure's AMT-130.

AI has the potential to transform life sciences commercialization, but only if we design it around people. Machines bring ...

Chatbots weren't designed for mental health, but they are increasingly used for therapy. What are the risks an benefits?

Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...

In a sea of cutting-edge technologies and bold predictions about the future, IT Tech Week Los Angeles 2025 saw an unexpected breakthrough – not in software or robotics, but in the realm of functional ...

Engineer Paul Salmon leads a movement to make conversational AI more human, empathetic, and trustworthy.

Accuray's weak quarter signals ongoing challenges despite new CEO plans. Discover key insights and risks before investing in ...

Ten stocks soared higher on Wednesday, mirroring a broader market rally, as investors continued to take path from a flurry of ...

Researchers tested an LLM-powered robot's ability to fetch butter. The result? Today’s models still struggle at basic ...

CMS is expanding coverage for remote patient monitoring in its 2026 Medicare Physician Fee Schedule, while a major payer is scaling back reimbursement to two specific use cases.

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...